000 | 01712 a2200469 4500 | ||
---|---|---|---|
005 | 20250516202743.0 | ||
264 | 0 | _c20150220 | |
008 | 201502s 0 0 eng d | ||
022 | _a1460-2202 | ||
024 | 7 |
_a10.3109/02713683.2014.885533 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFan, Chuanfeng | |
245 | 0 | 0 |
_aComparison of clinical efficacy of intravitreal ranibizumab with and without triamcinolone acetonide in macular edema secondary to central retinal vein occlusion. _h[electronic resource] |
260 |
_bCurrent eye research _cSep 2014 |
||
300 |
_a938-43 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAngiogenesis Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlucocorticoids _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIntravitreal Injections |
650 | 0 | 4 |
_aMacular Edema _xdrug therapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aRanibizumab |
650 | 0 | 4 |
_aRetinal Vein Occlusion _xcomplications |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aTriamcinolone Acetonide _xtherapeutic use |
650 | 0 | 4 |
_aVisual Acuity _xphysiology |
700 | 1 | _aWang, Yu | |
700 | 1 | _aJi, Qiang | |
700 | 1 | _aZhao, Bojun | |
700 | 1 | _aXie, Juan | |
773 | 0 |
_tCurrent eye research _gvol. 39 _gno. 9 _gp. 938-43 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3109/02713683.2014.885533 _zAvailable from publisher's website |
999 |
_c23646490 _d23646490 |